As of May 2023 CRISPR Therapeutics has a market cap of $5.04 Billion. This makes CRISPR Therapeutics the world's 2376th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On May 30th, 2023 the market cap of CRISPR Therapeutics was reported to be:
|Name||Market cap||Market cap differencediff.||Country|
|$0.22 B||-95.50%||🇺🇸 USA|